POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER Drug Patent Profile

When do Potassium Chloride 20meq In Plastic Container patents expire, and when can generic versions of Potassium Chloride 20meq In Plastic Container launch?

Potassium Chloride 20meq In Plastic Container is a drug marketed by Baxter Hlthcare and Otsuka Icu Medcl and is included in two NDAs.

The generic ingredient in POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER is potassium chloride. There are two hundred and forty drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Potassium Chloride 20meq In Plastic Container

A generic version of POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER was approved as potassium chloride by ACTAVIS LABS FL INC on April 10^th, 2002.

Summary for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	314
Patent Applications:	3,628
DailyMed Link:	POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER at DailyMed

Pharmacology for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

Drug Class	Osmotic Laxative Potassium Salt
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

US Patents and Regulatory Information for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	potassium chloride	INJECTABLE;INJECTION	019904-006	Dec 17, 1990	AP	RX	Yes	Yes
Otsuka Icu Medcl	POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	potassium chloride	INJECTABLE;INJECTION	020161-006	Aug 11, 1998	AP	RX	Yes	Yes
Baxter Hlthcare	POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	potassium chloride	INJECTABLE;INJECTION	019904-002	Dec 26, 1989	AP	RX	Yes	Yes
Otsuka Icu Medcl	POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	potassium chloride	INJECTABLE;INJECTION	020161-002	Nov 30, 1992	AP	RX	Yes	Yes

Market Dynamics and Financial Trajectory for Potassium Chloride 20mEq in Plastic Container

Last updated: March 12, 2026

What are the current market conditions for potassium chloride 20mEq in plastic containers?

The global potassium chloride market is driven by expanding uses in medical, agricultural, and industrial sectors. The specific formulation of 20mEq in plastic containers primarily targets the pharmaceutical segment, especially intravenous (IV) therapy and electrolyte replenishment.

Market size and growth

• The global potassium chloride market was valued at approximately USD 3.5 billion in 2022[1].
• Compound annual growth rate (CAGR) is projected at 4.1% from 2023 to 2030[2].

Pharmaceutical segment focus

• The intravenous electrolyte replacement segment dominates, with an estimated 55% of total potassium chloride sales.
• The segment grew at a CAGR of around 3.8% during 2018-2022[3].

Top producers and markets

• Major producers include Mölnlycke, B. Braun Melsungen, and Baxter International.
• North America accounts for about 40% of global demand, driven by hospital and clinical settings.
• Europe and Asia-Pacific follow with growth rates near 4.5% annually.

How does formulation and packaging influence market dynamics?

Formulation specifics

• The 20mEq dose targets adult IV therapy, balancing efficacy and safety.
• Patient safety concerns limit dosage variability.

Packaging considerations

• Plastic containers offer lightweight, cost-effective, and sterile options.
• Regulatory standards dictate material safety, influencing supplier choices.

What are the competitive and regulatory influences?

Regulatory environment

• US FDA and European Medicines Agency (EMA) enforce strict standards on IV electrolytes.
• Good Manufacturing Practice (GMP) compliance is mandatory, impacting manufacturing costs.

Competitive landscape

• Key players invest in production capacity and formulation innovation.
• Proprietary packaging and sterilization techniques provide competitive advantages.

Pricing trends

• Median procurement cost for 20mEq potassium chloride in plastic containers ranges from USD 0.05 to 0.15 per unit (500 mL bag).
• Price sensitivity exists in hospital procurement, with negotiations lowering costs.

What is the financial outlook?

Revenue projections

• Potential global sales reach USD 4.5 billion by 2030, considering growth in healthcare infrastructure and electrolyte therapy demand[4].

Profit margins

• Gross margins are approximately 30-35%, driven by raw material costs and manufacturing efficiencies.
• R&D expenses are relatively low due to established formulations but may increase with new packaging or safety features.

Investment considerations

• Supply chain stability, particularly post-pandemic, influences pricing.
• Innovations in packaging, such as smart containers with usage tracking, could command premium pricing.

How does the product's market trajectory compare to alternatives?

Product Type	Market Share (2022)	CAGR (2023–2030)	Key Advantage
Potassium Chloride in Plastic Containers	65%	4.1%	Cost-effective, sterile, lightweight
Multi-dose or glass containers	20%	2.5%	Higher durability, reusable
Novel electrolyte solutions	15%	8.0%	Improved safety, extended stability

Summary of key market factors

• Strong demand driven by medical applications.
• Price competition constrained by regulatory and safety standards.
• Continuous capacity expansion by main producers.
• Regulatory compliance impacts cost and time-to-market.
• Innovation focus lies in safer packaging and delivery mechanisms.

---

Key Takeaways

• The potassium chloride 20mEq in plastic container segment shows steady growth within the global electrolyte market.
• Growth opportunities exist in emerging markets and through technological innovations.
• Pricing remains competitive but constrained by strict regulatory standards.
• Investment in production capacity and safety features influences profitability.
• Market share dominance belongs to established global pharmaceutical companies.

---

FAQs

What are the primary medical applications for potassium chloride 20mEq in plastic containers?
Electrolyte replacement in IV therapy, addressing hypokalemia, and rehydration protocols.

How does regulatory oversight impact production costs?
Strict GMP compliance raises manufacturing costs but ensures safety and market access.

Are there significant regional differences in market demand?
Yes. North America leads due to hospital infrastructure, while Asia-Pacific exhibits rapid growth driven by developing healthcare systems.

What factors influence pricing fluctuation?
Raw material costs, supply chain stability, regulatory compliance, and competitive negotiations.

Is there potential for packaging innovations to affect market share?
Yes. Smart, safety-enhanced containers may command premium pricing and capture market segments focused on patient safety.

---

References

[1] MarketsandMarkets. (2022). Potassium Chloride Market Forecast.
[2] Grand View Research. (2023). Electrolyte Solutions Market Analysis.
[3] IQVIA. (2022). Global Pharmaceutical Sales Data.
[4] BCC Research. (2023). Injectable Solutions Market Outlook.